Phase I Alimta Combination With BMS-275183 (Oral Taxane)

Trial Profile

Phase I Alimta Combination With BMS-275183 (Oral Taxane)

Phase of Trial: Phase I/II

Latest Information Update: 09 Mar 2010

At a glance

  • Drugs BMS 275183; Pemetrexed
  • Indications Non-small cell lung cancer
  • Focus Adverse reactions; Therapeutic Use
  • Sponsors Bristol-Myers Squibb
  • Most Recent Events

    • 22 May 2009 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at so we can help.

Back to top